| scholarly article | Q13442814 |
| P2093 | author name string | Jieh-Juen Yu | |
| Bernard P Arulanandam | |||
| Annette R Rodriguez | |||
| M Neal Guentzel | |||
| Thomas G Forsthuber | |||
| Nikita H Trivedi | |||
| P2860 | cites work | Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function | Q83859246 |
| New developments in mast cell biology | Q24634390 | ||
| The role of mast cells in the defence against pathogens | Q26825776 | ||
| T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells | Q28286584 | ||
| Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization | Q28366668 | ||
| Stable dry powder formulation for nasal delivery of anthrax vaccine | Q28386405 | ||
| Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4 | Q28513447 | ||
| Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48 | Q28574579 | ||
| Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues | Q30434434 | ||
| Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. | Q32133550 | ||
| Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin | Q33336048 | ||
| Mast cells initiate early anti-Listeria host defences | Q80832242 | ||
| Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF | Q82459138 | ||
| Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis | Q82872518 | ||
| Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokine production, and protease composition | Q33358546 | ||
| The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen | Q33451335 | ||
| Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response | Q33516501 | ||
| Mast cell and T cell communication; amplification and control of adaptive immunity | Q33663940 | ||
| Mast cell peptidases: chameleons of innate immunity and host defense | Q33695892 | ||
| Biological implications of preformed mast cell mediators | Q33744155 | ||
| Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium | Q33769220 | ||
| Mast cells enhance T cell activation: Importance of mast cell-derived TNF. | Q33772139 | ||
| Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6 | Q33860019 | ||
| Adenosine derived from Staphylococcus aureus-engulfed macrophages functions as a potent stimulant for the induction of inflammatory cytokines in mast cells | Q33913181 | ||
| Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation | Q34068978 | ||
| Monomeric IgE and mast cell development, survival and function | Q34196245 | ||
| Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide | Q34531494 | ||
| The role of mast cells in host defense and their subversion by bacterial pathogens | Q34543572 | ||
| Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification | Q34579554 | ||
| Mast cell activators: a new class of highly effective vaccine adjuvants | Q34772018 | ||
| Mast cell-orchestrated immunity to pathogens | Q35747350 | ||
| Plasticity in mast cell responses during bacterial infections | Q35767129 | ||
| Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis | Q35980874 | ||
| Mast cells in the development of adaptive immune responses | Q36015885 | ||
| The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. | Q36416493 | ||
| New and emerging roles for mast cells in host defence | Q36663431 | ||
| Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. | Q36756839 | ||
| Mast cells--key effector cells in immune responses | Q36776875 | ||
| Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. | Q36946043 | ||
| Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation | Q36949900 | ||
| Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes | Q37110147 | ||
| Mast cell functions in the innate skin immune system | Q37136142 | ||
| Secreted phospholipases A(2): A proinflammatory connection between macrophages and mast cells in the human lung. | Q37560322 | ||
| Advances in mast cell biology: new understanding of heterogeneity and function | Q37665290 | ||
| Mast cells: emerging sentinel innate immune cells with diverse role in immunity | Q37777229 | ||
| Cognate interactions between mast cells and helper T lymphocytes | Q37864550 | ||
| The impact of bacterial infection on mast cell degranulation | Q37952138 | ||
| Mast cells as critical effectors of host immune defense against Gram-negative bacteria | Q37987573 | ||
| TLR signaling in mast cells: common and unique features | Q38025397 | ||
| Intracellular Staphylococcus aureus-induced NF-κB activation and proinflammatory responses of P815 cells are mediated by NOD2. | Q39333880 | ||
| Staphylococcus aureus evades the extracellular antimicrobial activity of mast cells by promoting its own uptake | Q39528464 | ||
| Influence of Pseudomonas aeruginosa quorum sensing signal molecule N-(3-oxododecanoyl) homoserine lactone on mast cells | Q39865747 | ||
| Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. | Q40137003 | ||
| Streptococcus pneumoniae induces mast cell degranulation | Q40306435 | ||
| A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells | Q40371983 | ||
| Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells | Q40379301 | ||
| Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli | Q40578879 | ||
| Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways | Q40702335 | ||
| Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells. | Q40989006 | ||
| Rat peritoneal mast cells present antigen to a PPD-specific T cell line | Q41438798 | ||
| Novel collectin/C1q receptor mediates mast cell activation and innate immunity | Q41912340 | ||
| Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing | Q42193685 | ||
| Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine | Q42206416 | ||
| Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules | Q42755341 | ||
| Mast cells protect mice from Mycoplasma pneumonia | Q42906117 | ||
| Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node | Q43190653 | ||
| Compound 48/80 causes oxidative stress in the adrenal gland of rats through mast cell degranulation | Q43249347 | ||
| IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. | Q43545333 | ||
| Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha | Q43743353 | ||
| Selective activation of human intestinal mast cells by Escherichia coli hemolysin | Q43887631 | ||
| Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection | Q44640663 | ||
| Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin | Q44673847 | ||
| Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation | Q44820489 | ||
| Methylene blue administration in the compound 48/80-induced anaphylactic shock: hemodynamic study in pigs | Q45032643 | ||
| The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections | Q45134515 | ||
| Mast cell granules modulate alveolar macrophage respiratory-burst activity and eicosanoid metabolism | Q45150888 | ||
| IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses | Q46170288 | ||
| Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. | Q47229699 | ||
| Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands | Q47971946 | ||
| Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. | Q48230335 | ||
| Adoptive transfer of mast cells does not enhance the impaired survival of Kit(W)/Kit(W-v) mice in a model of low dose intraperitoneal infection with bioluminescent Salmonella typhimurium | Q50090875 | ||
| Mast cells determine the magnitude of bacterial toxin-induced skin inflammation. | Q52916937 | ||
| IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. | Q54023208 | ||
| T-cells subsets and activation in bronchial mucosa of sensitized Brown-Norway rats after single allergen exposure. | Q54167098 | ||
| IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. | Q54437625 | ||
| Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes | Q57194436 | ||
| Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders | Q70037295 | ||
| Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes | Q71740206 | ||
| Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts | Q72407601 | ||
| Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo | Q73100796 | ||
| Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes | Q73765715 | ||
| Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1 | Q73812148 | ||
| In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9 | Q73812151 | ||
| Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation | Q74477281 | ||
| MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation | Q78014788 | ||
| Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis | Q79415988 | ||
| IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis | Q79933186 | ||
| The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo | Q80141337 | ||
| P433 | issue | 2 | |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 129-138 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | Mast cells: multitalented facilitators of protection against bacterial pathogens | |
| P478 | volume | 9 |
| Q26777983 | Cathelicidin impact on inflammatory cells |
| Q38152817 | Clinical view on the importance of dendritic cells in asthma |
| Q40565515 | Contribution of FcɛRI-associated vesicles to mast cell-macrophage communication following Francisella tularensis infection |
| Q33631655 | Epistemology of the origin of cancer: a new paradigm |
| Q37739797 | Expression of surface and intracellular Toll-like receptors by mature mast cells |
| Q39041187 | IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells |
| Q55332003 | Mast Cells Are Activated by Streptococcus pneumoniae In Vitro but Dispensable for the Host Defense Against Pneumococcal Central Nervous System Infection In Vivo. |
| Q88906490 | Mast cell activators as novel immune regulators |
| Q90240746 | Mast cells are critical for controlling the bacterial burden and the healing of infected wounds |
| Q38633155 | Mast cells in asthma--state of the art. |
| Q50500416 | Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation. |
| Q47130424 | The Role of Mast Cells in Tuberculosis: Orchestrating Innate Immune Crosstalk? |
| Q40287757 | α-Hemolysin enhances Staphylococcus aureus internalization and survival within mast cells by modulating the expression of β1 integrin |
Search more.